Aptamer-Based Electrochemical Biosensing for Pumpless THC Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for detecting tetrahydrocannabinol (THC) lack sensitivity, are affected by temperature, and require specialized training, while microfluidic devices for sample processing rely on complex pumps or valve-based mechanisms.

Innovation Solution

Aptamer-based electrochemical biosensors with microfluidic devices that utilize aptamers specifically binding to THC, enabling sensitive and rapid detection without moving parts, using a pumpless or valveless design and electrochemical detection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional detection methods (immunoassays, spectrophotometry, colorimetry, mass spectrometry) are used, then detection can be performed, but sensitivity is insufficient and specialized training is required

Engineering Contradiction:
Improvedetection sensitivityVSAvoidoperational complexity
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The patent replaces complex mechanical and optical detection systems (spectrophotometry, colorimetry, mass spectrometry) with an electrochemical detection system. The electrochemical biosensor uses electron transfer reactions between redox molecules and the electrode to generate measurable electrical signals, eliminating the need for specialized optical or mass spectrometric equipment and the training required to operate them.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the detection parameter from optical properties (absorbance, color) or mass-to-charge ratio to electrochemical properties (current, potential). By measuring electrical current generated from redox reactions at the electrode surface, the system achieves high sensitivity while using simple, widely available electrochemical workstations rather than complex specialized equipment.

Inventive Principle:
Principle #35Parameter changes

2Ease of operation

If microfluidic devices use pumps or valve-based mechanisms, then fluid manipulation is achieved, but device complexity increases and moving parts create reliability issues

Engineering Contradiction:
Improvedevice simplicityVSAvoidmoving parts failure
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent extracts and removes the pumps and valves from the microfluidic system. Instead of using active mechanical components to manipulate fluids, the design relies on passive fluid transport through capillary action and pressure-driven flow, eliminating moving parts that could fail and simplifying the overall device architecture.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The microfluidic device performs fluid manipulation autonomously without external mechanical actuators. Capillary forces and pressure gradients naturally drive sample flow through the channels to the electrochemical sensing zone, allowing the system to self-regulate fluid movement without pumps or valves.

Inventive Principle:
Principle #25Self-service

3Measurement precision

If aptamers are labelled with redox indicator molecules, then electrochemical detection sensitivity is improved, but manufacturing complexity increases

Engineering Contradiction:
Improvedetection sensitivityVSAvoidaptamer production complexity
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The patent uses redox indicator molecules (methylene blue, ferrocene, ferricyanide) as intermediary signal amplifiers. These molecules bind to the aptamer or are incorporated into its structure, serving as mediators that convert the biological recognition event (aptamer-target binding) into a measurable electrochemical signal, thereby amplifying detection sensitivity without requiring complex aptamer synthesis.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent creates composite structures combining nucleic acid aptamers with redox-active molecules. The aptamer provides specific target recognition while the redox molecule provides signal generation capability, creating a hybrid biomaterial that achieves both high specificity and high sensitivity while remaining manufacturable through established chemical synthesis methods.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Achieves nanomolar-level detection of THC with high sensitivity and ease of use, suitable for point-of-care settings, and eliminates the need for complex instrumentation.

Implementation Method 1

the electrode-bound aptamers undergo conformational changes that affect electron transfer (ET) efficiency between the redox molecule and the electrode

Methodology Applied
Scientific EffectElectron transfer (ET): Redox Reactions

Implementation Method 2

Upon interaction with their targets, the electrode-bound aptamers undergo conformational changes that affect electron transfer (ET) efficiency between the redox molecule and the electrode

Methodology Applied
Scientific EffectConformational changes:

Implementation Method 3

the aptamer is not labelled with the methylene blue and the methylene blue competes with the target for binding with the aptamer

Methodology Applied
Scientific EffectCompetitive binding: Adsorption

Data Source

PatentUS20250251394A1Aptamer-based electrochemical drug detection assay
Publication Date: 2025.08.07 9383-7011 QUEBEC INC (STRËM)
  • US20250251394A1 patent drawing
  • US20250251394A1 patent drawing
  • US20250251394A1 patent drawing

AI summary

Aptamers configured to specifically bind to tetrahydrocannabinol and cannabidiol are disclosed, and biosensing methods and biosensor devices are described in which such aptamers are employed for detection of tetrahydrocannabinol and/or cannabidiol, with a limit of detection in the nanomolar range. In some example implementations, aptamer-based electrochemical biosensors are disclosed for sensitive and rapid detection of tetrahydrocannabinol and/or cannabidiol. Examples of microfluidic biosensors are disclosed that may be utilized in point-of-care settings.